Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Governance Other
confidence 75%
filed 2026-06-24
Item 8.01
The Board of Trustees approved a material change to the Fund's 80% investment policy effective August 28, 2026, broadening the definition of eligible investments to include "income-producing investments" beyond traditional corporate debt, and expanding the types of instruments that may be counted toward the policy. This is a governance decision affecting the Fund's fundamental investment mandate and requires 60-day shareholder notice, making it material to investors' understanding of the Fund's strategy and operations.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-24
Item 8.01
The Board of Trustees approved a material change to the Fund's 80% investment policy effective August 28, 2026, broadening the definition of eligible investments to include income-producing investments beyond corporate debt obligations. This is a governance event—a board-approved policy amendment affecting the Fund's investment mandate—that would materially affect investor expectations about the Fund's portfolio composition and risk profile. While not a named governance category (such as an executive appointment or auditor change), it clearly falls within governance-related matters requiring board approval and shareholder notification.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-24
Item 8.01
The Board of Trustees approved a change to the Fund's 80% investment policy effective August 28, 2026, expanding the definition of eligible investments to include a broader range of income-producing instruments and fixed income securities. This is a material governance and policy amendment affecting the Fund's investment mandate and strategy, disclosed under Item 8.01 (Other Events). While not a named governance category (such as an executive appointment or auditor change), it represents a significant policy decision by the board that would affect investor expectations about the Fund's portfolio composition and risk profile.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-24
Item 8.01
The filing discloses a material change to the Fund's investment guidelines effective July 24, 2026, permitting unlimited investment in commercial mortgage-related securities and allowing up to 50% of assets in below-investment-grade debt. This is a governance/policy matter affecting the Fund's permitted investment scope and risk profile, which would materially affect investor assessment of the Fund's strategy and risk exposure. While not a traditional governance event (board action, executive change, or shareholder vote), it represents a significant policy change that falls under governance_other as a material fund governance disclosure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund disclosed material changes to its investment strategy effective June 24, 2026 and July 24, 2026, permitting it to invest in and/or originate loans (including residential/commercial real estate, consumer loans, and other types) and to invest without limitation in defaulted bonds. These are significant expansions of the Fund's principal investment strategies that would materially affect investor expectations regarding portfolio composition, risk profile, and asset allocation, warranting disclosure under Item 8.01 as a strategic policy change.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
PIMCO High Income Fund disclosed a material change to its principal investment strategy, effective June 24, 2026, permitting the Fund to invest in and/or originate loans (including residential/commercial real estate, consumer loans, and bank loans without limitation as of July 24, 2026). This is a significant operational and strategic shift in the Fund's permitted investment scope, disclosed via prospectus supplement. While not a traditional M&A, debt issuance, or financial event, this represents a material change to the Fund's investment mandate and risk profile that would affect investor decision-making.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund disclosed material changes to its principal investment strategy effective June 24, 2026 and July 24, 2026, permitting it to invest in and/or originate loans (including subprime loans) and to invest without limitation in defaulted bonds. These are significant operational and strategic expansions of the Fund's investment mandate that would affect a reasonable investor's assessment of the Fund's risk profile and investment approach, disclosed via prospectus supplement (Exhibit 99.1).
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund disclosed a material change to its principal investment strategy effective June 24, 2026, permitting it to invest in and/or originate loans (residential, commercial, consumer, etc.) as a core strategy. This is a significant operational and strategic shift disclosed via prospectus supplement, affecting the Fund's investment mandate and risk profile. While not fitting a specific named category, this is clearly an operational/strategic business event material to investors in the Fund.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund disclosed a material change to its principal investment strategy, effective June 24, 2026, to permit investment in and/or origination of loans (residential, commercial, consumer, etc.). This is a significant operational and strategic shift in the Fund's permitted activities, disclosed via prospectus supplement. While not fitting the specific categories of M&A, debt issuance, or other named financial events, this represents a material change to the Fund's investment mandate and risk profile that would affect investor decision-making.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 7.01
The Board of Trustees declared a regular monthly distribution to shareholders of Oaktree Strategic Credit Fund on June 23, 2026, specifying gross and net distribution amounts per share across four share classes (Class I, D, S, and T), with a record date of June 26, 2026 and payment date of July 29, 2026.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund disclosed its monthly NAV per share ($22.41 as of May 31, 2026), aggregate NAV (~$4.5 billion), portfolio fair value (~$6.9 billion), debt levels (~$2.8 billion), and leverage ratio (0.60x), along with the status of ongoing public and private share offerings.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-06-24
Item 3.01
Definitive Healthcare received written notice from Nasdaq on June 18, 2026, that it failed to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days until December 15, 2026, to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
Item 1.01
Chewy entered into a new $600 million seven-year senior secured term loan credit facility on June 23, 2026, and amended its existing ABL Credit Agreement to extend maturity to June 23, 2031, creating material direct financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-24
Item 2.03
Oncor completed a sale of A$750 million (approximately US$525 million) of 5.70% Senior Secured Notes due June 24, 2033 on June 24, 2026. This is a clear creation of a direct financial obligation through debt issuance, disclosed under Item 2.03. The notes are secured by a lien on Oncor's transmission and distribution property and carry customary events of default, making this a material capital-raising event for the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Kymera's Annual Meeting of Shareholders held on June 24, 2026. The filing reports the final voting tallies for three proposals: election of Class III directors (Bruce Booth, Nello Mainolfi, John Maraganore, and Elena Ridloff), non-binding advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities. This is a material governance event affecting the composition of the board and auditor ratification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
Item 2.03
The Company increased commitments under its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation from $140 million to $165 million and increased the maximum principal amount from $310 million to $335 million. This amendment to an existing credit facility creates or expands a direct financial obligation, which is the hallmark of debt_issuance under Item 2.03. The increase in available borrowing capacity is material to a BDC's financing flexibility and capital structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 8.01
The filing discloses the declaration of a second quarter 2026 supplemental dividend of $0.03 per share, payable on July 13, 2026 to shareholders of record as of June 26, 2026. This is a clear dividend distribution event. As a BDC, dividend distributions are material to shareholders and affect the total return profile of the investment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
Item 1.01
Stanley Black & Decker entered into two material credit facilities on June 18, 2026: a $1.0 billion 364-Day Credit Agreement and a $2.0 billion Amended and Restated Five Year Credit Agreement, representing the creation of $3.0 billion in committed credit capacity. The prior 364-Day Credit Agreement dated June 23, 2025 was terminated in connection with the new facility, constituting a refinancing of the company's credit arrangements.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-24
Item 8.01
Western Union amended its Delayed Draw Term Loan Credit Agreement on June 17, 2026, extending the Commitment Period from July 8, 2026 to November 10, 2026. This is a material amendment to an existing credit facility that extends the company's borrowing window, affecting its financial flexibility and capital structure. While it does not fit the specific categories of debt_issuance (which typically covers new debt creation) or covenant_breach, it is clearly a material financial event involving modification of a direct financial obligation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder vote results from Disc Medicine's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing reports voting outcomes on three proposals: election of Class III directors (Donald Nicholson, John Quisel, and William White), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
Item 1.01
Mercury General entered into a Second Amended and Restated Credit Agreement on June 24, 2026, establishing a $250 million unsecured revolving credit facility maturing in 2031. This refinancing of the company's existing credit facility represents a material creation of a direct financial obligation affecting the registrant's liquidity and financial flexibility.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-24
Item 1.02
Item 1.02 discloses termination of a material definitive agreement and incorporates Item 1.01 by reference. Without visibility into the specific agreement terminated and circumstances, the precise nature of this event cannot be determined, though the explicit 'Material Definitive Agreement' language indicates materiality.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 8.01
Goldman Sachs announced an increase in its common dividend from $4.50 to $5.00 per share, effective July 1, 2026, representing an 11% increase from current levels and 25% relative to the prior year. This is a material capital allocation decision that would affect a reasonable investor's assessment of the firm's shareholder return strategy and capital deployment priorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of WaterBridge Infrastructure's 2026 annual shareholder meeting held on June 18, 2026. The filing presents certified voting results for four proposals: election of 13 directors (all elected), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency (approved annually). The disclosure is material as it confirms shareholder approval of board composition and governance matters affecting the registrant's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of LandBridge's 2026 annual meeting of shareholders held on June 18, 2026. The filing presents voting results for four proposals: election of 11 directors (all elected), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency (one year approved). The disclosure is material as it documents shareholder approval of board composition and governance matters.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-06-24
Item 1.01
On June 18, 2026, Sportsman's Warehouse entered into two material credit agreements: an Amended and Restated ABL Term Loan Credit Agreement extending a $45.0 million term loan to June 18, 2031, and a Third Amendment to the Amended and Restated Credit Agreement providing a $315 million senior secured revolving credit facility (reduced from $350 million) with the same maturity date. These refinancings and amendments constitute material amendments to the Company's direct financial obligations and credit facilities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 1.01
Absci entered into an underwriting agreement on June 24, 2026 to issue 13,495,277 shares of common stock at $7.41 per share, generating approximately $100 million in gross proceeds ($93.5 million net) pursuant to an effective Form S-3 shelf registration statement. The offering includes participation from strategic investors including Eli Lilly & Company and materially dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-24
Item 8.01
The filing's primary disclosure is Bank of New York Mellon's announcement of a 19% increase in its quarterly cash dividend from $0.53 to $0.63 per share, commencing in Q3 2026, subject to Board approval. While the filing also discusses stress test results and share repurchase authorization, the dividend increase is the lead announcement and the material capital allocation decision disclosed in Item 8.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MediciNova's 2026 annual meeting of stockholders held on June 23, 2026. The filing presents voting results for four proposals: election of two Class I directors (Hikedi Nagao and Nicole Lemerond), ratification of BDO USA as auditor, approval of an amendment to increase authorized shares (which failed to pass), and approval of adjournment. The material outcome is the failure of the share authorization increase proposal, which did not receive majority support from outstanding shares.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-06-24
EX-99.1
The exhibit announces a 1-for-25 share consolidation explicitly undertaken to "regain compliance with Nasdaq Marketplace Rule 5550(a)(2) (minimum bid price of at least $1 per share) and maintain its listing on the Nasdaq Capital Market." This is a direct response to delisting risk triggered by failure to meet the minimum bid price rule, making it a material disclosure of action taken to avoid delisting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-24
Item 5.07
i-80 Gold held its annual shareholder meeting on June 23, 2026, at which shareholders approved setting the board at nine directors, elected all nine director nominees, and reappointed Grant Thornton LLP as the company's independent auditors.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-24
Item 5.02
The Company amended and restated executive employment agreements for CEO James Rolke and CFO Chester S. Zygmont, III, effective June 24, 2026, increasing change-in-control severance benefits to 2x base salary plus target bonus with COBRA reimbursement up to 18 months, expanding flexibility for outside activities, and establishing a three-year initial term with automatic renewal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
At the Annual Meeting of Stockholders held on June 24, 2026, stockholders approved three proposals: election of Jennifer Carver as a Class A director, authorization of reverse stock splits in a range of one-for-two to one-for-250, and ratification of Baker Tilly US, LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder voting results from Scilex Holding Company's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports voting outcomes on three proposals: election of a Class I director (Dorman Followwill), ratification of BPM LLP as independent auditor, and approval of an amendment to the 2022 Equity Incentive Plan to increase authorized shares. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This Item 5.07 filing discloses the results of Fidus Investment Corporation's 2026 annual meeting of stockholders held on June 24, 2026. The filing reports voting results for two proposals: (1) election of Class III directors (Raymond Anstiss, Jr. and Edward H. Ross), and (2) approval to sell or issue shares below net asset value. Both proposals were approved by stockholders, with specific vote tallies provided for each nominee and proposal. This is a classic shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The Fund disclosed an unregistered sale of LLC units (equity securities) for $66.97 million pursuant to a capital call notice delivered to investors on June 22, 2026. The issuance is exempt under Section 4(a)(2) and Regulation D, which are hallmarks of private placements. This is a material capital raise that increases the Fund's equity base and dilutes existing unit holders' ownership percentages.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
Shareholders voted at the June 22, 2026 Annual Meeting on three proposals: election of Class I director Asher Genoot, ratification of KPMG LLP as independent auditor, and approval of a reverse stock split charter amendment (1-for-5 to 1-for-40 ratio at board discretion). All proposals were approved.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-24
Item 8.01
The board approved implementation of a 1-for-15 reverse stock split following shareholder approval at the Annual Meeting, materially affecting the company's share structure and existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
Fortress Private Lending Fund completed an unregistered sale of 182,155 Class I common shares for $4.4 million to accredited investors under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-06-24
Item 8.01
The fund declared a June 2026 monthly distribution of $0.1812 per share, payable on or about July 22, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
CalciMedica entered into a securities purchase agreement for a private placement of approximately $49 million in gross proceeds, comprising 18,673,429 units of common stock (or pre-funded warrants), Series A warrants, and Series B warrants. The unregistered securities rely on Section 4(a)(2) exemption and carry restrictive legends, with potential for up to $34 million additional proceeds if warrants are exercised.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 8.01
CalciMedica announced a focused pulmonary hypertension strategy using proceeds from the private placement, including a planned Phase 1b proof-of-concept study with Auxora and advancement of CM5480 toward IND clearance. The FDA also cleared the company to continue the KOURAGE trial following review of interim safety data and protocol amendments.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 85%
filed 2026-06-24
Item 8.01
The filing discloses that FiscalNote's Class A common stock was delisted from the NYSE, triggering defaults under subordinated convertible debt instruments held by GPO and YA. The Company negotiated forbearance agreements to waive these defaults until July 21, 2026. This is a covenant breach event—the delisting triggered contractual defaults that accelerated or increased direct financial obligations, and the forbearance arrangement is a material restructuring of debt terms to avoid acceleration.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-24
EX-99.1
Apollomics received a Nasdaq deficiency notice dated June 18, 2026, stating non-compliance with the minimum Market Value of Listed Securities (MVLS) requirement of $35 million under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days (until December 15, 2026) to regain compliance or face delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent for a foreign private issuer.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 7.01
Teamshares announced that its common stock began trading on Nasdaq under the new ticker symbol "TMS" on June 23, 2026, accompanied by a press release and investor presentation. This represents a material operational and strategic milestone—the company's transition to public markets—which would affect a reasonable investor's assessment of the registrant's capital structure, liquidity, and future financing options. While this is a significant corporate event, it does not fit neatly into the specific event-type categories (it is not M&A, not a governance change per se, not a financial obligation, and not a restatement or impairment). The disclosure is clearly operational/strategic in nature, making `operational_other` the most appropriate classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-24
Item 1.01
Gores Holdings XI completed a $358.8 million initial public offering, including entry into multiple material definitive agreements (Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, and Registration Rights Agreement) that establish the company's initial public structure and capital formation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The company issued 225,000 Class A Ordinary Shares to the Sponsor at $10.00 per share for $2.25 million in gross proceeds pursuant to Section 4(a)(2) of the Securities Act of 1933, a private placement concurrent with the IPO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-24
Item 5.02
Three new directors—Randall Bort, Keith Covington, and Elizabeth Marcellino—were appointed to the board on June 22, 2026, in connection with the company's IPO, with Bort chairing the Audit Committee and Marcellino chairing the Compensation Committee.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-24
Item 1.01
Identiv entered into a Stock and Asset Purchase Agreement on June 24, 2026, to sell its specialty Internet of Things business to Trackonomy Systems, Inc. for $50 million in Series C Preferred Stock plus assumption of liabilities, subject to stockholder approval. The transaction is expected to result in a name change and strategic pivot to SaaS and physical AI.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-24
Item 8.01
Identiv's Board authorized an increase to the company's stock repurchase program from $10 million to $40 million, with $1.88 million already repurchased under the program.
View raw filing on EDGAR →